Healthy male subject
Conditions
Interventions
Ingestion of trial supplement A for 4 weeks
Ingestion of trial supplement B for 4 weeks
Ingestion of trial supplement C for 4 weeks
Ingestion of placebo for 4 weeks
Sponsors
FANCL Corporation
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Japanese males aged from 20 to less than 65 years old. 2) Subjects whose serum uric acid levels are included within 6.0mg/dL and 8.0mg/dL.
Exclusion criteria
Exclusion criteria: 1) Subjects who are under treatment or have a history of hyperuricemia or gout. 2) Subjects who have a history of gouty arthritis or gouty arthritis. 3) Subjects who are under treatment or have a history of rheumatoid arthritis. 4) Subjects who have a history of urinary stone or kidney stone. 5) Subjects who has a disease under treatment or are judged to that medical treatment are necessary by the doctor 6) Subjects who have under treatment or history of disease such as diabetes, liver disease, kidney disease, heart disease, adrenal cortex disease. 7) Subjects who are routinely use the health food, dietary supplement, and medicine including over-the-counter drug for improving of serum uric acid. 8) Subjects who routinely use or are planned to use analgesics (non-steroidal analgesics, steroidal analgesics, etc.). 9) Subjects with allergies to the products used in the study. 10) Subjects who are planned to change their lifestyle. 11) Subjects who have participated in other clinical study within the last one month prior to the current study 12) Subjects who are judged as unsuitable for the study by the investigator for other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum uric acid level | — |
Secondary
| Measure | Time frame |
|---|---|
| Urine uric acid level Subgroup analysis using SNP Relationship among serum uric acid, urine uric acid, and SNP | — |
Countries
Japan
Contacts
Public ContactYoshiki Shimizu
FANCL CORPORATION Research institute
Outcome results
None listed